WifOR Institute

The WHO projects a deficit of 4.1 million healthcare professionals by 2030 in the EU. But how many vacancies are unfilled in your specific sector, and how can these gaps be closed? WifOR Institute assesses workforce shortages to help healthcare and social care organizations plan for their future. Our research provides: ✓ Data on labor gaps by region, occupation, and qualification ✓ Forecasts up to 2040 across Europe ✓ Analysis of the results for policy and corporate strategies ⬇️ Learn how the health and social care workforce is evolving – and what your organization can do to adapt.

Across Europe, hospitals, nursing homes, and daycare centers are struggling to find and retain qualified staff. WifOR Institute is assessing these shortages and defining solutions to close labor gaps. Our research on personnel deficits in healthcare and social care helps organizations plan for future workforce needs. Our insights and recommendations include: ✓ Current and forecasted bottlenecks in specific occupations ✓ Training, integration, and digitalization as levers to combat personnel deficits ✓ Examples of how governments and companies are using our data Learn more in our guide ⬇️

The health and social care sector urgently needs workers, but how can it attract and retain talent? WifOR Institute analyzes branch-specific labor shortages and proposes solutions to address bottlenecks. As healthcare providers and other organizations must adapt to the shrinking workforce, our insights dive into: ✓ How personnel gaps are widening – and recommendations to close them ✓ How the share of international workers increases, driving integration needs ✓ How to use workforce forecasts to plan for future staff requirements Download our guide to learn more ⬇️

Understanding the societal and economic value of health is essential for informed decision-making across healthcare, policy, and industry. Join experts from WifOR Institute and Novartis to discover how the Social Impact of Health (SIoH) Framework translates health improvements into measurable productivity gains across both paid and unpaid work, making the broader value of health visible. 📅 September 17th, 2026 | 2:00–3:00 PM (CET) 🎓 Free Online Masterclass Register now!

Drug prices are increasing compared across countries – raising the need to show economic value locally to strengthen a company’s position in pricing and policy discussions. WifOR Institute’s Economic Footprint Analysis provides a structured, data-based foundation for engagement with decision-makers. It demonstrates national economic contribution, supports reimbursement discussions That are aligned with government priorities. 📥 Download the guide to see how economic impact is used in practice.

New pricing policies are pushing drug prices downward – while increasing pressure to prove local economic value, not just performance. Leading pharma companies already use the Economic Footprint to quantify their contribution to jobs, GDP, and innovation – and strengthen their position in pricing and policy discussions with a data-based view. 📥 Download the guide to see how industry leaders apply this approach.